Laronidase

In the US, Laronidase (laronidase systemic) is a member of the drug class lysosomal enzymes and is used to treat Mucopolysaccharidosis Type I.

US matches:

• Laronidase


• Laronidase Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A16AB05

CAS registry number (Chemical Abstracts Service)

0210589-09-6

Chemical Formula

C3567-H5645-N921-O1261-S12-P4

Molecular Weight

82117

Therapeutic Categories

Enzyme

Enzyme, replacement therapy

Chemical Name

8-L-histidine-alfa-L-iduronidase (human) (WHO)

Foreign Names

• Laronidasum (Latin)
• Laronidase (German)
• Laronidase (French)
• Laronidasa (Spanish)

Generic Names

• Laronidase (OS: USAN)
• alfa-Iduronidase (IS)
• alfa-L-Iduronidase (IS)
• Alronidase (IS)
• BM 101 (IS)
• Iduronidase, alfa-L-[8-histidine] (IS: human)
• NZ 1002 (IS: Novazyme)

Brand Names

• Aldurazyme
  Genzyme, Austria; Genzyme, Australia; Genzyme, Belgium; Genzyme, Bulgaria; Genzyme, Canada; Genzyme, Switzerland; Genzyme, Czech Republic; Genzyme, Germany; Genzyme, Denmark; Genzyme, Spain; Genzyme, Finland; Genzyme, France; Genzyme, United Kingdom; Genzyme, Greece; Genzyme, Ireland; Genzyme, Israel; Genzyme, Italy; Genzyme, Luxembourg; Genzyme, Netherlands; Genzyme, Norway; Genzyme, Romania; Genzyme, Sweden; Genzyme, Slovenia; Genzyme, Slovakia; Genzyme, United States; Medical Intertrade, Croatia (Hrvatska)

International Drug Name Search

Glossary

IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.